Dren Bio
Signal active
Organization
Contact Information
Overview
Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
About
Industries
Biotechnology, Life Science, Health Care
Founded
2019
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Dren Bio headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care sector. The company focuses on Biotechnology and has secured $9.3B in funding across 60 round(s). With a team of 11-50 employees, Dren Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Corporate Round - Dren Bio, raised $25.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
1
Lead Investors
0
Total Funding Amount
$155.1M
Details
3
Dren Bio has raised a total of $155.1M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 60.0M | ||
| 2021 | Early Stage Venture | |||
| 2022 | Early Stage Venture | 65.0M |
Investors
Dren Bio is funded by 31 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Dren Bio | - | FUNDING ROUND - Dren Bio | 65.0M |
| HBM Partners | - | FUNDING ROUND - HBM Partners | 65.0M |
| Dren Bio | - | FUNDING ROUND - Dren Bio | 25.0M |
| Novartis | - | FUNDING ROUND - Novartis | 25.0M |
Recent Activity
There is no recent news or activity for this profile.